Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Rafael Herranz"'
Autor:
Carla Fernández-García, Mariana H.G. Monje, Víctor Gómez-Mayordomo, Guglielmo Foffani, Rafael Herranz, Maria José Catalán, Mercedes González-Hidalgo, Jorge Matias-Guiu, Fernando Alonso-Frech
Publikováno v:
Brain Stimulation, Vol 15, Iss 3, Pp 727-736 (2022)
Background: Directional subthalamic stimulation in Parkinson's disease can increase stimulation threshold for adverse effects and widen the therapeutic window. However, selection of programming settings is time consuming, requiring a thorough monopol
Externí odkaz:
https://doaj.org/article/1e908f019b0d4c9da8603a85f9b7e5a4
Autor:
Rocío Orsi, Ricardo Gutiérrez Aguilar, Isabel García Adánez, José Luis López de Lizaga, Rafael Herranz, Fernando Bayón, Alfonso Galindo Hervás, Julián Sauquillo, Alan Scopel, José María Rosales, Javier Peña, Antonio Casado da Rocha, Francisco Javier Miranda Vallejo, Alberto Sucasas, Manuel Sánchez Rodríguez, Marta García-Alonso, Nuria Sánchez Madrid
Publikováno v:
Isegoría, Iss 39, Pp 373-446 (2008)
Externí odkaz:
https://doaj.org/article/6c5f3747f066476daae8783c24e3a7ab
Autor:
José Manuel Sánchez Fernández, Karina P. Trilles Calvo, Rocío Orsi, Pedro Cerezo Galán, Ricardo Gutiérrez Aguilar, Rafael Herranz Castillo, Amparo Gómez, Iván Teimil García, Iñigo González, Alberto Sucasas, Bernardino Orio de Miguel, Salvador Mas
Publikováno v:
Isegoría, Iss 37, Pp 285-329 (2007)
Externí odkaz:
https://doaj.org/article/762d1fea231241c892b7ab844e2840da
Autor:
Ángel Rivera Rodríguez, Concha Roldán Panadero, José Antonio Gimbemat, Juan Carlos Velasco Arroyo, Elena Beltrán, Julián Sauquillo, José María Mardones, Rafael Herranz Castillo
Publikováno v:
Isegoría, Iss 13, Pp 205-238 (1996)
Externí odkaz:
https://doaj.org/article/3b015e2ab45b42429509a3971216f4c9
Autor:
Juan G. Morán, Rafael Herranz Castillo, Ángeles J. Perona, Carlos Thiebaut, Albert Calsamiglia, Jaime Yilchis, José Miguel Marinas
Publikováno v:
Isegoría, Iss 9, Pp 207-231 (1994)
Externí odkaz:
https://doaj.org/article/978d0678c3eb4c618b8e7231b18715c6
Autor:
Rafael Herranz Castillo
Publikováno v:
Revista de las Cortes Generales, Pp 281-288 (1985)
Recensión de la obra: Elías Díaz: «De la maldad estatal y la soberanía popular». Edit. Debate, Madrid, 1984
Externí odkaz:
https://doaj.org/article/51d0626a4ab24dfa95f049855caba84e
Autor:
Rafael Herranz Castillo
Publikováno v:
Revista de las Cortes Generales, Pp 409-418 (1986)
Recensión de la obra: Cosi, Giovanni. Saggio sulla disobbedienza civile. Storia e critica del dissenso in democrazia. Milán, A. Giuffré Edit., 1984.
Externí odkaz:
https://doaj.org/article/998cd901e46b4763be4da07eb1271a2b
Autor:
David, García-García1,2, Rafael, Herranz-Hernandez3, Ayelén, Rojas-Benedicto1,2, Inmaculada, León-Gómez1,2, Amparo, Larrauri1,2, Marina, Peñuelas2, María, Guerrero-Vadillo2, Rebeca, Ramis1,2, Diana, Gómez-Barroso1,2 dgomez@isciii.es
Publikováno v:
BMC Public Health. 2/2/2022, Vol. 22 Issue 1, p1-7. 7p. 2 Charts, 2 Graphs.
Autor:
David García-García, Rafael Herranz-Hernández, Ayelén Rojas-Benedicto, Inmaculada León-Gómez, Amparo Larrauri, Marina Peñuelas, María Guerrero-Vadillo, Rebeca Ramis, Diana Gómez-Barroso
Publikováno v:
Repisalud
Instituto de Salud Carlos III (ISCIII)
Instituto de Salud Carlos III (ISCIII)
Background After a national lockdown during the first wave of the COVID-19 pandemic in Spain, regional governments implemented different non-pharmaceutical interventions (NPIs) during the second wave. Aim To analyse which implemented NPIs significant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41c79f523a2d222ed74854690c32245d
https://hdl.handle.net/20.500.12105/14658
https://hdl.handle.net/20.500.12105/14658
Autor:
Gianna Vargas Centanaro, Myriam Calle Rubio, José Luis Álvarez-Sala Walther, Fernando Martinez-Sagasti, Andrea Albuja Hidalgo, Rafael Herranz Hernández, Juan Luis Rodríguez Hermosa
Publikováno v:
Open Forum Infectious Diseases. 9
Background LUNG INJURY COVID-19 (clinicaltrials.gov NCT 21/399-E) is a registry-based prospective observational cohort study to evaluate long-term outcomes and recovery 12 months after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infe